As biotechnology and pharmaceutical professionals continue efforts to make advances in medicinal drug formulation, safety and efficacy, experts in the field…
A small biotech, armed with technology out of Cornell University and a former Dana-Farber chief at its helm, has raised $90 million for its cancer drugs.
Members of the Cornell entrepreneurial community gathered to celebrate a successful first year of the Read More
It’s time for the real world: Three brand new robust companies – one turning carbon dioxide into jet fuel, another enabling a green hydrogen economy and a…
In September, Cornell startup companies Halomine and Inso Biosciences were awarded the New York State Biodefense Commercialization Fund to prevent
Among the promising group of life science researchers and business students in the inaugural cohort of the Read More
Cornell has been awarded a $15 million, five-year grant from the National Science Foundation to lead a newly established Innovation Corps (I-Corps) Hub that…
A virtual discussion featuring startup founders bringing novel innovation to the life sciences. Panelists will highlight the fact that the majority of…
